Course Description:
Leadership is fundamental to the success of individuals and organisations. As you progress in your biomedicine career, you will have to lead individuals, teams and organisations. This course prepares you to lead, by equipping you with principles, skills and practices of leadership.
Course Description:
This course serves as a concept-based introduction to biostatistics, or to the use of numerical technique to extract information from data and facts. It is aimed at students, researchers and healthcare professionals who wish to learn modern research methods. The learning objectives are to communicate scientific results, develop tools to investigate the inherent variability introduced by sampling and quantify uncertainty before progressing to the process of making inference about the population. Using computer software such as SPSS, the concepts and the statistical methods will be illustrated based on the real life data arising from selected scientific and medical studies.
Course Description:
This module introduces the pharmacological treatment of infectious diseases. It covers the actions of drugs, how they target and eliminate pathogens, and the mechanisms through which they exert their effects. This course will use various examples of antimicrobial agents, including antibiotics, antivirals, antifungals, and antiparasitic agents, to illustrate the fundamental principles of pharmacotherapy in infectious diseases. We will also explore the drug discovery and development process, highlighting the journey from basic research to clinical application. The students will gain a comprehensive understanding of the drugs used to combat infectious diseases and the ongoing challenges in developing new therapeutic agents.
Course Description:
This course will introduce different classes of anticancer agents-their discovery and development, mode of action, mechanisms of resistance, side effects and clinical applications. It aims to describe (i) how various anticancer drugs can be used both individually and in combination for the management of the various cancers, and (ii) how advances in biomarker discovery may help in patient stratification for precision oncology. It will also provide and integrated understanding of all aspects of anticancer drug development process ranging from initial design through final approval for clinical application.
